Rowland M - Search Results

1

Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years.

Rowland M, Noe CR, Smith DA, Tucker GT, Crommelin DJ, Peck CC, Rocci ML Jr, Besançon L, Shah VP. Rowland M, et al. J Pharm Sci. 2012 Nov;101(11):4075-99. doi: 10.1002/jps.23295. Epub 2012 Aug 21. J Pharm Sci. 2012. PMID: 22911654

2

Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002).

Rowland M, Balant L, Peck C. Rowland M, et al. AAPS PharmSci. 2004 Feb 9;6(1):E6. doi: 10.1208/ps060106. AAPS PharmSci. 2004. PMID: 15198507 Free PMC article.

3

Physiologically-based pharmacokinetics in drug development and regulatory science.

Rowland M, Peck C, Tucker G. Rowland M, et al. Annu Rev Pharmacol Toxicol. 2011;51:45-73. doi: 10.1146/annurev-pharmtox-010510-100540. Annu Rev Pharmacol Toxicol. 2011. PMID: 20854171 Review.

4

Intracellular and Intraorgan Concentrations of Small Molecule Drugs: Theory, Uncertainties in Infectious Diseases and Oncology, and Promise.

Smith DA, Rowland M. Smith DA, et al. Among authors: rowland m. Drug Metab Dispos. 2019 Jun;47(6):665-672. doi: 10.1124/dmd.118.085951. Epub 2019 Mar 25. Drug Metab Dispos. 2019. PMID: 30910784 Review.

5

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.

Lesko LJ, Rowland M, Peck CC, Blaschke TF. Lesko LJ, et al. Among authors: rowland m. Pharm Res. 2000 Nov;17(11):1335-44. doi: 10.1023/a:1007574217260. Pharm Res. 2000. PMID: 11205725 Review. No abstract available.

6

Lead PK commentary: predicting human pharmacokinetics.

Rowland M, Benet LZ. Rowland M, et al. J Pharm Sci. 2011 Oct;100(10):4047-9. doi: 10.1002/jps.22637. Epub 2011 May 31. J Pharm Sci. 2011. PMID: 21630278 No abstract available.

7

Impact of target interactions on small-molecule drug disposition: an overlooked area.

van Waterschoot RAB, Parrott NJ, Olivares-Morales A, Lavé T, Rowland M, Smith DA. van Waterschoot RAB, et al. Among authors: rowland m. Nat Rev Drug Discov. 2018 Apr;17(4):299. doi: 10.1038/nrd.2018.26. Epub 2018 Feb 23. Nat Rev Drug Discov. 2018. PMID: 29472637 No abstract available.

8

Importance of target-mediated drug disposition for small molecules.

Smith DA, van Waterschoot RAB, Parrott NJ, Olivares-Morales A, Lavé T, Rowland M. Smith DA, et al. Among authors: rowland m. Drug Discov Today. 2018 Dec;23(12):2023-2030. doi: 10.1016/j.drudis.2018.06.010. Epub 2018 Jun 19. Drug Discov Today. 2018. PMID: 29928850 Review.

9

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.

Lesko LJ, Rowland M, Peck CC, Blaschke TF. Lesko LJ, et al. Among authors: rowland m. J Clin Pharmacol. 2000 Aug;40(8):803-14. doi: 10.1177/00912700022009530. J Clin Pharmacol. 2000. PMID: 10934664

10

Microdosing: a critical assessment of human data.

Rowland M. Rowland M. J Pharm Sci. 2012 Nov;101(11):4067-74. doi: 10.1002/jps.23290. Epub 2012 Aug 23. J Pharm Sci. 2012. PMID: 22927093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,030 results

Search Page

Filters